Send us Feedback

Osiris Therapeutics (OSIR)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

OSIR » Topics » SIGNATURE

This excerpt taken from the OSIR 10-Q filed May 22, 2008.

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

Osiris Therapeutics, Inc.

 

 

Date: May 22, 2008

/s/ PHILIP R. JACOBY, JR.

 

Philip R. Jacoby, Jr.

 

Interim Chief Financial Officer

 

3

This excerpt taken from the OSIR 10-Q filed May 12, 2008.
SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Osiris Therapeutics, Inc.

 

 

 

Date: May 12, 2008

 

/s/ PHILIP R. JACOBY, JR.

 

 

Philip R. Jacoby, Jr.

 

 

Interim Chief Financial Officer

 

18

This excerpt taken from the OSIR 10-Q filed Nov 13, 2007.
SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Osiris Therapeutics, Inc.

 

 

 

Date: November 13, 2007

 

/s/ Cary J. Claiborne

 

 

Cary J. Claiborne

 

 

Chief Financial Officer

 

20

This excerpt taken from the OSIR 10-Q filed Aug 10, 2007.
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Osiris Therapeutics, Inc.

 

 

 

Date: August 10, 2007

 

/s/ Cary J. Claiborne

 

 

Cary J. Claiborne

 

 

Chief Financial Officer

 

18


This excerpt taken from the OSIR 10-Q filed May 14, 2007.
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Osiris Therapeutics, Inc.

 

 

 

 

 

 

Date: May 14, 2007

 

/s/ Cary J. Claiborne

 

 

Cary J. Claiborne

 

 

Chief Financial Officer

 

 

16


This excerpt taken from the OSIR 10-Q filed Nov 13, 2006.
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

Osiris Therapeutics, Inc.

 

 

 

 

 

 

Date: November 13, 2006

 

/s/ Cary J. Claiborne

 

 

Cary J. Claiborne

 

 

Chief Financial Officer

 

21


This excerpt taken from the OSIR 10-Q filed Sep 15, 2006.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Osiris Therapeutics, Inc.

 

 

 

 

 

 

 

 

 

 

Date: September 15, 2006

 

 

 

/s/ Cary J. Claiborne

 

 

 

 

Cary J. Claiborne

 

 

 

 

Chief Financial Officer

 

23


EXCERPTS ON THIS PAGE:

10-Q
May 22, 2008
10-Q
May 12, 2008
10-Q
Nov 13, 2007
10-Q
Aug 10, 2007
10-Q
May 14, 2007
10-Q
Nov 13, 2006
10-Q
Sep 15, 2006

RELATED TOPICS for OSIR:

"SIGNATURE" elsewhere:

AGENUS INC (AGEN)
Corcept Therapeutics (CORT)
Curis (CRIS)
GPC Biotech AG (GPCB)
GTC Biotherapeutics (GTCB)
IGI (IG)
Metabasis Therapeutics (MBRX)
Biota Pharmaceuticals, Inc. (NABI)
Neurobiological Technologies (NTII)
Polydex Pharmaceuticals (POLXF)
Peregrine Pharmaceuticals (PPHM)
Sunesis Pharmaceuticals (SNSS)
Savient Pharmaceuticals (SVNT)
Theravance (THRX)
SYNAGEVA BIOPHARMA CORP (TRMS)
Vical (VICL)
XOMA (XOMA)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki